West Pharmaceutical Services, Inc. (NYSE: WST) provides injectable drug administration solutions and services for pharmaceutical, biotechnology and generic drug customers. Its business includes elastomer-based packaging components such as stoppers, seals and plungers, nonglass containment technologies, auto-injectors and contract services for device manufacturing, assembly, packaging, validation, analytical testing and regulatory support.
News about West commonly covers quarterly results, revenue guidance, Proprietary Products and Contract Manufacturing performance, capacity additions for high-volume injectable therapies, and demand tied to biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. Other recurring developments include dividends, share repurchase authorizations, investor conference participation and governance or executive-transition updates.
West Pharmaceutical Services (NYSE: WST) announced its participation in the William Blair 44th Annual Growth Stock Conference in Chicago, IL, on June 4, 2024, at 8:00 AM CT. The event will feature a live audio webcast available on the company's website, www.westpharma.com, in the 'Investors' section. The webcast replay will be accessible for 90 days post-event.
West Pharmaceutical Services, Inc. (NYSE: WST) will participate in the Bank of America Securities Healthcare Conference in Las Vegas, NV on May 14, 2024. The company will present at 11:20 AM PT and offer a live audio webcast on their website. Investors can access the webcast on www.westpharma.com.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.